<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-1SIFYX54</identifier><date>1998</date><creator>Auersperg, Marija</creator><relation>documents/doc/1/URN_NBN_SI_doc-1SIFYX54_001.pdf</relation><relation>documents/doc/1/URN_NBN_SI_doc-1SIFYX54_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 109-112</format><identifier identifier_type="COBISSID_HOST">9650137</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-1SIFYX54</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Zveza slovenskih društev za boj proti raku</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">Antineoplastic agents</subject><subject language_type_id="eng">Therapy</subject><subject language_type_id="eng">Thyroid neoplasms</subject><subject language_type_id="eng">Treatment outcome</subject><title>Kombinirano zdravljenje raka ščitnice s kemoterapijo, obsevanjem in operacijo</title></Record>